|
Filler firms tangle over patent rights: Medicis, Inamed say action won't affect ability of dermatologists to get Restylane or Hylaform.(News)(Brief Article)
Publication: Skin & Allergy News Publication Date: 01-JUL-04 Author: Splete, Heidi
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2004 International Medical News Group
Filler may fly as Inamed and Medicis Aesthetics argue the patent rights to an injection technique.
Inamed, which markets Hylaform injectable hyaluronic acid dermal filler in the United States, has petitioned the U.S. International Trade Commission (ITC) go investigate possible patent infringement by Medicis Aesthetics, which markets Restylane injectable...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Necrotic spider bites.(Letters)(Letter to the Editor)
July 01, 2004
|
MDs want single-payer plan.(Letters)(Letter to the Editor)
July 01, 2004
|
'No insurance' isn't 'no care'.(Letters)(Letter to the Editor)
July 01, 2004
|
Medical community decries FDA's plan B decision.(News)
July 01, 2004
|
Doctors, not lawyers, best cure for liability woes.(News)
July 01, 2004
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
